Results: 935 news stories
Peter T. Fox, MD, director of the Research Imaging Institute at ¸£ÀûÒ»ÇøÔÚÏß, Department of Radiology, was quoted in this article. Read More
A scientist at The University of Texas at San Antonio was recently awarded two grants totaling more than $4.6 million from the National Institutes of Health to study how cells repair DNA to protect the genome, the set of genetic instructions within our cells.
In a study published April 13 in Nature Communications, scientists at The University of Texas at San Antonio found a link between a bacterium in the gut microbiome and lupus, which could lead to more effective treatment of the disease.
A third-year MD/PhD graduate student from The University of Texas at San Antonio (UT San Antonio), Christopher Mullally, recently received funding from the National Institutes of Health National Cancer Institute for a project examining how the body regulates internal sources of mutation and how breakdowns in that regulation may contribute to cancer development. While […]
Ralph DeFronzo, MD, professor of medicine and chief of the Diabetes Division, led new research showing that people with resistant hypertension and lower kidney function are more likely to have hypercortisolism, highlighting the potential value of screening high-risk patients for the condition. The study was featured in the June 21 issue of HCP Live.
This brief notes that a legislative push by the House Armed Services Committee, directing military leadership to investigate access pathways to psychedelic therapies for service members, follows a recent DOD award of $4.9 million to ¸£ÀûÒ»ÇøÔÚÏß and Emory University to study MDMA-assisted therapy for PTSD. Read More
Stephanie Haddad, DO, hematology-oncology fellow physician and wellness chief fellow at Mays Cancer Center at ¸£ÀûÒ»ÇøÔÚÏß, was interviewed about fellowship, research, wellness and oncology for an episode of Empowering Oncologists on OncoDaily. Watch Now
Valerie F. Shiu, MD, Division of Dermatology, and Mohs microsurgeon at Mays Cancer Center at ¸£ÀûÒ»ÇøÔÚÏß, was interviewed for this news segment. Watch Now
Maria Smereka-Hladio found a welcoming, collaborative culture during her interview at the Joe R. and Teresa Lozano Long School of Medicine and was inspired by an environment where the students genuinely supported one another.
UT San Antonio now ranks in the top 13%, placing 296 out of 2,250 institutions worldwide. UT San Antonio’s research enterprise is recognized as a globally competitive leader in clinical and academic research, innovation and impact.
Alan Peterson, PhD, Department of Psychiatry and Behavioral Sciences, and director of the STRONG STAR Consortium, was interviewed for this news segment. Watch Now
Researchers at ¸£ÀûÒ»ÇøÔÚÏß recently explored a possible way to make exercise more rewarding for older adults. Their study investigated whether a nutritional supplement called branched-chain amino acids, commonly known as BCAAs, could help reduce fatigue and improve the benefits of exercise. Jason O’Connor, PhD, an associate professor of pharmacology involved in the […]
Research by the STRONG STAR Consortium, led by ¸£ÀûÒ»ÇøÔÚÏß, examined the link between traumatic events and the development of fibromyalgia in a longitudinal cohort study involving 1,761 United States military service members. The results of the study were published in January 2026 in Arthritis Care & Research. Read More
The University of Texas at San Antonio met its accreditation standards as a merged university, completing the required process for institutional-level accreditation for a merger as affirmed by the Southern Association of Colleges and Schools Commission on Colleges (SACSCOC).
A randomized clinical trial published in JAMA Network Open, and led by Peter T. Fox, MD, director of the Research Imaging Institute at ¸£ÀûÒ»ÇøÔÚÏß, suggests that an advanced MRI-guided form of transcranial magnetic stimulation (TMS) may significantly improve outcomes when added to intensive residential therapy for combat-related PTSD. Read More
The PediQEESIâ„¢ is a new structured screening and documentation tool to help parents and clinicians recognize patterns among a child’s symptoms, exposures and daily functioning. The tool was developed by the TILT Research Program for Chemical Intolerance at ¸£ÀûÒ»ÇøÔÚÏß, the academic health center of The University of Texas at San Antonio.
OncLive: HERTHENA-Breast04 Is Set to Delineate the Role of HER3-Targeted Therapy in Advanced HR+ Breast Cancer
MedPage Today: Accumulating Evidence Lifts GLP-1s to Clinical Trial for Breast Cancer Prevention
Becker’s Dental + DSO Review: DSOs, dental schools and companies secure $270M in funding boons
Healio: HemOnc Today announces 2026 Disruptive Innovators